Rheumatoid Arthritis Complicated with Nasal Septum Perforation Due to Methotrexate-associated Lymphoproliferative Disorder. 2019

Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
Department of Rheumatology, Japan Community Healthcare Organization, Isahaya General Hospital, Japan.

A 44-year-old female with rheumatoid arthritis treated with methotrexate (MTX) and tocilizumab (TCZ) was admitted to our hospital with nasal pain. Nasal fiberscopy revealed septum perforation, while a membrane biopsy indicated granuloma and fibrinoid necrosis of the small artery. The patient was treated with prednisolone 30 mg/day after discontinuation of MTX and TCZ. Inguinal lymph node biopsy revealed diffuse infiltrations of atypical T-cells and Epstein-Barr virus-positive B cells. The patient was diagnosed with peripheral T-cell lymphoma due to MTX-associated lymphoproliferative disorder (MTX-LPD). We herein describe the case of a patient with nasal septum perforation due to MTX-LPD mimicking granulomatosis with polyangiitis.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008232 Lymphoproliferative Disorders Disorders characterized by proliferation of lymphoid tissue, general or unspecified. Duncan's Syndrome,X-Linked Lymphoproliferative Syndrome,Duncan Disease,Epstein-Barr Virus Infection, Familial Fatal,Epstein-Barr Virus-Induced Lymphoproliferative Disease In Males,Familial Fatal Epstein-Barr Infection,Immunodeficiency 5,Immunodeficiency, X-Linked Progressive Combined Variable,Lymphoproliferative Disease, X-Linked,Lymphoproliferative Syndrome, X-Linked, 1,Purtilo Syndrome,X-Linked Lymphoproliferative Disease,X-Linked Lymphoproliferative Disorder,Disease, Duncan,Disease, X-Linked Lymphoproliferative,Diseases, X-Linked Lymphoproliferative,Disorder, Lymphoproliferative,Disorder, X-Linked Lymphoproliferative,Disorders, Lymphoproliferative,Disorders, X-Linked Lymphoproliferative,Epstein Barr Virus Induced Lymphoproliferative Disease In Males,Epstein Barr Virus Infection, Familial Fatal,Familial Fatal Epstein Barr Infection,Immunodeficiency 5s,Immunodeficiency, X Linked Progressive Combined Variable,Lymphoproliferative Disease, X Linked,Lymphoproliferative Diseases, X-Linked,Lymphoproliferative Disorder,Lymphoproliferative Disorder, X-Linked,Lymphoproliferative Disorders, X-Linked,Lymphoproliferative Syndrome, X-Linked,Lymphoproliferative Syndromes, X-Linked,Purtilo Syndromes,Syndrome, Purtilo,Syndrome, X-Linked Lymphoproliferative,Syndromes, Purtilo,Syndromes, X-Linked Lymphoproliferative,X Linked Lymphoproliferative Disease,X Linked Lymphoproliferative Disorder,X Linked Lymphoproliferative Syndrome,X-Linked Lymphoproliferative Diseases,X-Linked Lymphoproliferative Disorders,X-Linked Lymphoproliferative Syndromes
D008727 Methotrexate An antineoplastic antimetabolite with immunosuppressant properties. It is an inhibitor of TETRAHYDROFOLATE DEHYDROGENASE and prevents the formation of tetrahydrofolate, necessary for synthesis of thymidylate, an essential component of DNA. Amethopterin,Methotrexate Hydrate,Methotrexate Sodium,Methotrexate, (D)-Isomer,Methotrexate, (DL)-Isomer,Methotrexate, Dicesium Salt,Methotrexate, Disodium Salt,Methotrexate, Sodium Salt,Mexate,Dicesium Salt Methotrexate,Hydrate, Methotrexate,Sodium, Methotrexate
D009300 Nasal Septum The partition separating the two NASAL CAVITIES in the midplane. It is formed by the SEPTAL NASAL CARTILAGE, parts of skull bones (ETHMOID BONE; VOMER), and membranous parts. Nasal Septums,Septum, Nasal,Septums, Nasal
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis

Related Publications

Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
October 2019, World neurosurgery,
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
November 2019, Internal medicine (Tokyo, Japan),
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
September 2010, Presse medicale (Paris, France : 1983),
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
September 2023, Cancer science,
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
January 2013, European journal of dermatology : EJD,
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
May 2016, Japanese journal of ophthalmology,
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
April 2007, Journal of the American Academy of Dermatology,
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
March 2009, Actas dermo-sifiliograficas,
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
November 2008, Neurology,
Ryuki Sakaguchi, and Keita Fujikawa, and Momoko Okamoto, and Emi Matsuo, and Kohei Matsumoto, and Tomohisa Uchida, and Kawashiri Shin-Ya, and Masahiro Nakashima, and Akinari Mizokami, and Atsushi Kawakami
January 2013, Iranian journal of otorhinolaryngology,
Copied contents to your clipboard!